Free shipping on all orders over $ 500

 About 11 results found for searched term "AZ20" (0.058 seconds)

Cat.No.  Name Target
M1696 Cediranib VEGFR/PDGFR
AZD2171; NSC-732208
Cediranib (AZD2171) inhibited VEGFR2 and KDR phosphorylation with IC50s of 0.4 and 0.5 nM, respectively.
M2299 AZD2014 mTOR
Vistusertib
AZD2014 is a novel dual mTORC1 and mTORC2 inhibitor with potential antineoplastic activity.
M2412 AZ20 ATM/ATR
AZ20 is a novel potent and selective inhibitor of ATR kinase with IC50 of 5 nM, 8-fold selectivity over mTOR.
M45342 AZD-2207 Cannabinoid
AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound that can be used in studies related to type 2 diabetic disease and obesity.
M4810 AZD-1208 Pim
AZD1208
AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that effectively inhibits all three isoforms at <5 nM or <150 nM in enzyme and cell assays, respectively.
M6294 AZD-7594 GCR
AZ13189620
AZD7594 is an inhaled, nonsteroidal, potent, and selective modulator of the glucocorticoid receptor (GR). It is being developed for once-daily treatment of chronic obstructive pulmonary disease and asthma, either alone or in combination with a bronchodilator.
M6475 AZ 10606120 dihydrochloride P2 Receptor
AZ 10606120 dihydrochloride is a potent P2X 7 receptor antagonist.
M6481 AZD 2066 Others
AZD 2066 is a mGlu 5 antagonist; orally bioavailable and brain penetrant.
M10377 Golidocitinib (AZD4205) JAK
AZD-4205; Golidocitinib
Golidocitinib (AZD4205) is a novel potent and selective janus kinase 1 (JAK1) inhibitor, with IC50 value of 73 nM.
M13921 AZD2098 CCR
AZD2098 is a potent and selective CC-chemokine receptor 4 (CCR4) inhibitor with pIC50s of 7.8, 8.0, 8.0 and 7.6 for human, rat, mouse and dog respectively, used for asthma research.
M28240 AZD4320  Bcl-2
AZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.